Boehringer plans 3-year, $84M expansion in Mexico

勃林格殷格翰未来三年将投资8400万美元用于墨西哥糖尿病药物生产基地扩建

2019-05-27 16:32:00 pharma

本文共564个字,阅读需2分钟

Boehringer Ingelheim intends to make a significant investment in its three manufacturing sites in Mexico in the next three years, starting with its site near Mexico City where it makes diabetes meds.    The drugmaker today said it will invest about 1 billion Mexican pesos ($52 million) over the next two years in its Xochimilco site, a sum that should boost capacity. The goal is to increase production to 2.5 billion tablets annually in 2028 from about 1.6 billion tablets now, the company said, according to a translated story in Milenio.  RELATED: Boehringer Ingelheim builds $100M facility to launch complex solids The plant expansion, which will allow the German drugmaker to increase export capacity to the U.S. as well as to Argentina, Colombia and Brazil, was announced by Miguel Salazar, CEO of Boehringer in Mexico, Central America and the Caribbean, according to the report.   The expansion at the Xochimilco plant is part of an investment plan to invest 1.6 billion pesos ($84 million) by 2023 to boost production at all three of its production sites in the country, Manufacturing Chemist reports. The expansion in Mexico comes as the company has made some changes in the way it treats newer, more complex products as opposed to older products that are easier to manufacture.    Last year, Boehringer started construction on a $100 million R&D and manufacturing facility in Germany where it will both develop and manufacture more complex tablets for global launches. At the same time, it is moving production of what it calls “older, easier-to-manufacture drugs” to other sites worldwide.
勃林格殷格翰( Boehringer Ingelheim )打算在未来三年对其在墨西哥的三个生产基地进行重大投资,首先是在墨西哥城附近生产糖尿病药物。 这家制药商今天表示,未来两年将在其 Xochimilco 网站上投资约10亿墨西哥比索(合5200万美元),这一数额将提高产能。该公司表示,其目标是在2028年将年产量从现在的16亿片增加到25亿片。 相关:勃林格殷格翰(Boehringer Ingelheim)建造了价值1亿美元的设施,用于发射复杂固体 该报告称,博林格在墨西哥、中美洲和加勒比海地区的首席执行长萨拉查( Miguel Salazar )宣布了该工厂的扩建计划,这将使这家德国制药商能够增加对美国以及阿根廷、哥伦比亚和巴西的出口能力。 制造化学家报告说, Xochimilco 工厂的扩建是投资计划的一部分,计划到2023年投资16亿比索(8400万美元),以提高其在该国所有三个生产基地的产量。 墨西哥扩张之际,该公司在对待更新、更复杂产品的方式上做出了一些改变,而不是更容易制造的老产品。 去年, Boehringer 开始在德国建设一家1亿美元的研发和制造工厂,该公司将在德国开发和制造更复杂的平板电脑,用于全球发布。与此同时,该公司正在将其所称的“更老、更容易制造的药品”的生产转移到全球其他地区。

以上中文文本为机器翻译,存在不同程度偏差和错误;偶尔因源网页结构局限,内容无法一次完整呈现。请理解并参考原站原文阅读。

阅读原文